All In MedTech

Device Trial Radar · NCT00393549

NeuroPath Comparative Validation Study Plan

Last checked: Nov 20, 2026Latest source record: Jun 6, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

200

Planned (sponsor's estimate)

Start

Aug 2006

Primary completion

Not stated

Study completion Dec 2006

Sponsor

Lead sponsor
Excel-Tech Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Oct 30, 2006

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the study is to compare the performance of the NeuroPath automated nerve conduction test with the standard of care manual test in the diagnosis of entrapment neuropathies.

Conditions

  • Carpal Tunnel Syndrome (CTS)

Interventions

  • NeuroPathDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Validity of the NeuroPath

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Harmonex Neuroscience Research

    Dothan, Alabama

  • SunCoast Neuroscience Associateion

    St. Petersburg, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.